I-Flow Corporation, a subsidiary of Kimberly-Clark Corporation, has reached an agreement resolving patent infringement and trade secret litigation against Apex Medical Technologies and Zone Medical, effective from June 10, 2010.

Under the terms of the agreement, Apex and Zone will discontinue manufacturing and distribution of the Solace pump, surrender to I-Flow various pump-related tooling, and pay I-Flow undisclosed compensation.

Apex and Zone will be able to sell off up to 3,000 units of their remaining product inventory through August 13, 2010, in the US and the remaining inventory, an additional 3,000 units, in international markets until November 11, 2010.

As a result of the agreement, the patent litigation against Apex and Zone will be resolved, and Solace will cease to be manufactured and sold in the US and international markets.

I-Flow designs, develops and markets low-cost drug delivery systems and products for post-surgical pain relief and surgical site care. Its flagship product line is the ON-Q Post-Op Pain Relief System.